The biopharmaceutical industry is in the midst of an exciting transformation as biologics experience massive growth — even outpacing the small-molecule segment (1). Biologics are predicted to comprise over a quarter of the pharmaceutical market in 2020 (2). At the same time, a plethora of new biologically derived therapy concepts — e.g., cell and gene therapies — are in development. Some biologics classes have become mainstream — e.g., monoclonal antibodies — with biosimilars entering the market and contract manufacturing organizations…
Friday, December 20, 2019 Daily Archives
The 12 trends of Christmas: A look back at 2019
CAR-T partnerships, Biopharma megamergers, biotech funding, and an eye on China. Bioprocess Insider presents the biggest stories of the year… through song! T’was the days before Christmas, And all through the dept. Not a story was breaking and journalists wept. So why not look back at the news of the year, The editor suggested over a beer… In the past twelve months Bioprocess Insider brought to you (To the tune of traditional Christmas song ‘The Twelve Days of Christmas’): A…
A CDMO’s Perspective on the Development of Bioprocesses for Clinical Manufacturing Success
This webcast features: Nigel Shipston, Director, Program Design, FUJIFILM Diosynth Biotechnologies A strategy for the development and scale of bioprocesses should be assessed at the earliest of stages. There are different challenges depending on the molecule and expression system. This webinar is designed to address some of the areas of consideration for successful development of bioprocesses for biologics and gene therapies. At the end of this webinar, you will be able to do a self-assessment to answer some critical questions:…
Are you single-use or stainless-steel? Take our holiday quiz to find out
Does your heart beat when you see a large shiny tank fixed-fast to the wall of a giant redbrick facility, or do you get a warm feeling in your inside bioreactor when you see a plastic bag flexing its flexibility credentials across a modular cleanroom? It’s the end of the decade and while much has changed since December 2009, one of the biggest shake-ups in the bioprocess space is the advent of single-use systems. With single-use systems now being used…